...
首页> 外文期刊>Tumour biology : >microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1
【24h】

microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1

机译:microRNA-188在口腔鳞状细胞癌中被下调,并通过靶向SIX1抑制增殖和侵袭

获取原文
获取原文并翻译 | 示例

摘要

microRNA-188 expression is downregulated in several tumors. However, its function and mechanism in human oral squamous cell carcinoma (OSCC) remains obscure. The present study aims to identify the expression pattern, biological roles, and potential mechanism by which miR-188 dysregulation is associated with oral squamous cell carcinoma. Significant downregulation of miR-188 was observed in OSCC tissues compared with paired normal tissues. In vitro, gain-of-function, loss-of-function experiments were performed to examine the impact of miR-188 on cancer cell proliferation, invasion, and cell cycle progression. Transfection of miR-188 mimics suppressed Detroit 562 cell proliferation, cell cycle progression and invasion, with downregulation of cyclin D1, MMP9, and p-ERK. Transfection of miR-188 inhibitor in FaDu cell line with high endogenous expression exhibited the opposite effects. Using fluorescence reporter assays, we confirmed that SIX1 was a direct target of miR-188 in OSCC cells. Transfection of miR-188 mimics downregulated SIX1 expression. SIX1 siRNA treatment abrogated miR-188 inhibitor-induced cyclin D1 and MMP9 upregulation. In addition, we found that SIX1 was overexpressed in 32 of 80 OSCC tissues. In conclusion, this study indicates that miR-188 downregulation might be associated with oral squamous cell carcinoma progression. miR-188 suppresses proliferation and invasion by targeting SIX1 in oral squamous cell carcinoma cells.
机译:在几种肿瘤中,microRNA-188的表达下调。但是,其在人口腔鳞状细胞癌(OSCC)中的功能和机制仍然不清楚。本研究旨在确定miR-188失调与口腔鳞状细胞癌相关的表达模式,生物学作用和潜在机制。与配对的正常组织相比,在OSCC组织中观察到了miR-188的显着下调。在体外,进行了功能获得,功能丧失实验以检查miR-188对癌细胞增殖,侵袭和细胞周期进程的影响。 miR-188模拟物的转染抑制了底特律562细胞的增殖,细胞周期的进程和侵袭,并下调了细胞周期蛋白D1,MMP9和p-ERK。在高内源性表达的FaDu细胞系中转染miR-188抑制剂表现出相反的作用。使用荧光报告基因测定,我们证实SIX1是OSCC细胞中miR-188的直接靶标。 miR-188的转染模拟下调SIX1表达。 SIX1 siRNA处理废除了miR-188抑制剂诱导的细胞周期蛋白D1和MMP9的上调。此外,我们发现SIX1在80个OSCC组织中的32个中过表达。总之,这项研究表明miR-188的下调可能与口腔鳞状细胞癌的进展有关。 miR-188通过靶向SIX1抑制口腔鳞状细胞癌细胞的增殖和侵袭。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号